TriSalus Life Sciences, Inc.

NASDAQ:TLSI

Medical - Devices

Healthcare
$2.18 +0.49%

+$0.02 today

Market cap
$134.20M
Beta
0.49
P/E (TTM)
-7.4
EPS (TTM)
-$0.53
52W Low $2.20High $7.95

Volume 0.36M

Average 0.38M

Income Statement

Follow revenue through to earnings.

Revenue

$45.15M

FY 2025 · Annual

+53.4% YoY

Operating Income

-$26.95M

FY 2025 · Annual

Net Income

-$39.23M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue8.4M12.4M18.51M29.43M45.15M
Cost of Revenue1.19M2.26M2.61M4.1M6.97M
Gross Profit7.21M10.14M15.91M25.33M38.19M
Gross Margin85.8%81.8%85.9%86.1%84.6%
Research & Development14.22M21.36M29.84M17.69M14.97M
Selling, General & Admin17.02M25.22M40.55M43.81M50.17M
Operating Expenses31.24M46.58M70.38M61.49M65.13M
Depreciation & Amortization464K414K684K744K626K
EBITDA(26.62M)(46.76M)(58.65M)(32.39M)(33.05M)
EBITDA Margin-316.8%-377.2%-316.9%-110.0%-73.2%
Operating Income(24.03M)(36.44M)(54.48M)(36.17M)(26.95M)
Operating Margin-286.1%-293.9%-294.3%-122.9%-59.7%
Interest Income0180K431K404K555K
Interest Expense1.76M1K16K3.09M5.54M
Other Income / Expenses(4.81M)(10.74M)(4.88M)6.13M(12.27M)
Income Before Tax(28.84M)(47.18M)(59.35M)(30.04M)(39.22M)
Pre-Tax Margin-343.3%-380.5%-320.6%-102.1%-86.9%
Income Tax Expense3K9K9K6K7K
Net Income(28.85M)(47.19M)(59.36M)(33.23M)(39.23M)
Net Margin-343.4%-380.6%-320.7%-112.9%-86.9%
EPS (Basic)(0.92)(1.59)(2.23)(1.25)(1.84)
EPS (Diluted)(0.92)(1.59)(2.23)(1.25)(1.84)
Weighted Avg Shares31.25M29.61M26.47M26.5M49.19M
Weighted Avg Shares (Diluted)31.25M29.61M26.47M26.5M37.9M

TLSI Earnings Waterfall · TTM

NASDAQ:TLSI · Revenue to Net Income

Key Ratios

EPS$-1.41
Gross Margin85.1%
Net Margin-56.0%
P/E Ratio3.8
P/S Ratio20.3

Analysis

$44.9M of revenue converted into -$27.3M of net income for the selected period. Gross margin is 85.1% and net margin is -56.0%, showing how much revenue survives after costs and taxes. EPS is $-1.41, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026

How much revenue does TLSI generate?

TriSalus Life Sciences, Inc. (TLSI) reported $45.15M of revenue in fiscal 2025.

Is TLSI profitable?

TriSalus Life Sciences, Inc. (TLSI) reported -$39.23M of net income, with a net margin of -86.9%.